Deborah Kay Armstrong

Professor

1979 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Deborah Kay Armstrong is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 16 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Anti-cancer therapy and clinical trial considerations for gynecologic oncology patients during the COVID-19 pandemic crisis

Pothuri, B., Alvarez Secord, A., Armstrong, D. K., Chan, J., Fader, A. N., Huh, W., Kesterson, J., Liu, J. F., Moore, K., Westin, S. N. & Naumann, R. W., Jul 2020, In : Gynecologic oncology. 158, 1, p. 16-24 9 p.

Research output: Contribution to journalArticle

Open Access
  • A phase I study of intravenous or intraperitoneal platinum based chemotherapy in combination with veliparib and bevacizumab in newly diagnosed ovarian, primary peritoneal and fallopian tube cancer

    Moore, K. N., Miller, A., Bell-McGuinn, K. M., Schilder, R. J., Walker, J. L., O'Cearbhaill, R. E., Guntupalli, S. R., Armstrong, D. K., Hagemann, A. R., Gray, H. J., Duska, L. R., Mathews, C. A., Chen, A., O'Malley, D., Gordon, S., Fracasso, P. M. & Aghajanian, C., Jan 2020, In : Gynecologic oncology. 156, 1, p. 13-22 10 p.

    Research output: Contribution to journalArticle

  • A Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian Cancer

    Oza, A. M., Matulonis, U. A., Secord, A. A., Nemunaitis, J., Roman, L. D., Blagden, S. P., Banerjee, S., McGuire, W. P., Ghamande, S., Birrer, M. J., Fleming, G. F., Markham, M. J., Hirte, H. W., Provencher, D. M., Basu, B., Kristeleit, R., Armstrong, D. K., Schwartz, B., Braly, P., Hall, G. D. & 8 others, Nephew, K. P., Jueliger, S., Oganesian, A., Naim, S., Hao, Y., Keer, H., Azab, M. & Matei, D., Mar 1 2020, In : Clinical Cancer Research. 26, 5, p. 1009-1016 8 p.

    Research output: Contribution to journalArticle

  • Germline and somatic tumor testing in epithelial ovarian cancer: ASCO guideline

    Konstantinopoulos, P. A., Norquist, B., Lacchetti, C., Armstrong, D., Grisham, R. N., Goodfellow, P. J., Kohn, E. C., Levine, D. A., Liu, J. F., Lu, K. H., Sparacio, D. & Annunziata, C. M., Apr 10 2020, In : Journal of Clinical Oncology. 38, 11, p. 1222-1245 24 p.

    Research output: Contribution to journalArticle

  • Rucaparib for patients with platinum-sensitive, recurrent ovarian carcinoma (ARIEL3): post-progression outcomes and updated safety results from a randomised, placebo-controlled, phase 3 trial

    Ledermann, J. A., Oza, A. M., Lorusso, D., Aghajanian, C., Oaknin, A., Dean, A., Colombo, N., Weberpals, J. I., Clamp, A. R., Scambia, G., Leary, A., Holloway, R. W., Gancedo, M. A., Fong, P. C., Goh, J. C., O'Malley, D. M., Armstrong, D. K., Banerjee, S., García-Donas, J., Swisher, E. M. & 4 others, Cameron, T., Maloney, L., Goble, S. & Coleman, R. L., May 2020, In : The Lancet Oncology. 21, 5, p. 710-722 13 p.

    Research output: Contribution to journalArticle